Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Statement of Comprehensive Income

Johnson & Johnson, consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 29, 2019
Net earnings 35,153 17,941 20,878 14,714 15,119
Foreign currency translation (3,221) (1,796) (1,079) (233) 164
Unrealized holding gain (loss) arising during period 26 (24) (4) 1
Securities, net change 26 (24) (4) 1
Prior service credit (cost), net of amortization (149) (160) (169) 1,298 (18)
Gain (loss), net of amortization (1,183) 1,854 4,318 (1,135) (714)
Consumer settlement/curtailment 23
Effect of exchange rates (90) 111 106 (229) (1)
Employee benefit plans, net change (1,399) 1,805 4,255 (66) (733)
Unrealized gain (loss) arising during period 422 454 (199) 1,000 (107)
Reclassifications to earnings (569) (348) (789) (53) 7
Derivatives & hedges, net change (147) 106 (988) 947 (100)
Other comprehensive income (loss), net of tax (4,741) 91 2,184 649 (669)
Comprehensive income 30,412 18,032 23,062 15,363 14,450

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29).

Comprehensive income item Description The company
Net earnings The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Johnson & Johnson net earnings decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.
Comprehensive income Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Johnson & Johnson comprehensive income decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.